{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2019:UHTA7M5KJ65ZFP3ADOBHEQW4V5","short_pith_number":"pith:UHTA7M5K","canonical_record":{"source":{"id":"1903.09267","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2019-03-21T23:05:38Z","cross_cats_sorted":["stat.ML"],"title_canon_sha256":"f981943727c6b5d5d66dd64bf9e5c4dc750ffd46d6257cfd3e7b6f6e9d57e892","abstract_canon_sha256":"a68430f993901bbcc9cb96b03682e5290cc434c8c793d367d1d522070a866504"},"schema_version":"1.0"},"canonical_sha256":"a1e60fb3aa4fbb92bf601b827242dcaf51b34b307011cddb257f261b4349a7cd","source":{"kind":"arxiv","id":"1903.09267","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1903.09267","created_at":"2026-05-17T23:50:40Z"},{"alias_kind":"arxiv_version","alias_value":"1903.09267v1","created_at":"2026-05-17T23:50:40Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1903.09267","created_at":"2026-05-17T23:50:40Z"},{"alias_kind":"pith_short_12","alias_value":"UHTA7M5KJ65Z","created_at":"2026-05-18T12:33:30Z"},{"alias_kind":"pith_short_16","alias_value":"UHTA7M5KJ65ZFP3A","created_at":"2026-05-18T12:33:30Z"},{"alias_kind":"pith_short_8","alias_value":"UHTA7M5K","created_at":"2026-05-18T12:33:30Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2019:UHTA7M5KJ65ZFP3ADOBHEQW4V5","target":"record","payload":{"canonical_record":{"source":{"id":"1903.09267","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2019-03-21T23:05:38Z","cross_cats_sorted":["stat.ML"],"title_canon_sha256":"f981943727c6b5d5d66dd64bf9e5c4dc750ffd46d6257cfd3e7b6f6e9d57e892","abstract_canon_sha256":"a68430f993901bbcc9cb96b03682e5290cc434c8c793d367d1d522070a866504"},"schema_version":"1.0"},"canonical_sha256":"a1e60fb3aa4fbb92bf601b827242dcaf51b34b307011cddb257f261b4349a7cd","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-17T23:50:40.160032Z","signature_b64":"dArNISUvvCZrlF+3n14t+NPPOAdJnENhVbTV54bDrfqzsJ4PhJX1n2Exro1/3OYvui7+zvo2yaGfxd1c2rDcCA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"a1e60fb3aa4fbb92bf601b827242dcaf51b34b307011cddb257f261b4349a7cd","last_reissued_at":"2026-05-17T23:50:40.159451Z","signature_status":"signed_v1","first_computed_at":"2026-05-17T23:50:40.159451Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1903.09267","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-17T23:50:40Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"FkCX3Qi62YEVsJ7FvcydQ5HMpoSjIRVYJzWvjPntFyoZ1FIzoUoyFzWoa89icD7HH8+XJdmMGicbbigI9TVkCw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-10T19:05:45.909761Z"},"content_sha256":"a91de012c462196315c76dcf56c9580fbbd74795b3d0a93a749f46ab4d4301fc","schema_version":"1.0","event_id":"sha256:a91de012c462196315c76dcf56c9580fbbd74795b3d0a93a749f46ab4d4301fc"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2019:UHTA7M5KJ65ZFP3ADOBHEQW4V5","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"A Computer-Aided System for Determining the Application Range of a Warfarin Clinical Dosing Algorithm Using Support Vector Machines with a Polynomial Kernel Function","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["stat.ML"],"primary_cat":"cs.LG","authors_text":"Adam Bress, Ashkan Sharabiani, Houshang Darabi, Rezvan Nazempour, William Galanter","submitted_at":"2019-03-21T23:05:38Z","abstract_excerpt":"Determining the optimal initial dose for warfarin is a critically important task. Several factors have an impact on the therapeutic dose for individual patients, such as patients' physical attributes (Age, Height, etc.), medication profile, co-morbidities, and metabolic genotypes (CYP2C9 and VKORC1). These wide range factors influencing therapeutic dose, create a complex environment for clinicians to determine the optimal initial dose. Using a sample of 4,237 patients, we have proposed a companion classification model to one of the most popular dosing algorithms (International Warfarin Pharmac"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1903.09267","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-17T23:50:40Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"zgJwTX8qziedQQz6y7SFb6TEluIszSd/Z+ZOLLTwf7W7ZGQd5wrD+RiZfOqA7JalkyQDlyuNgzuXMCDO4JRyBA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-10T19:05:45.910116Z"},"content_sha256":"e516d53479e82fe3017b9469775d88f83455c4e4230048d9907598ef3d3f9d56","schema_version":"1.0","event_id":"sha256:e516d53479e82fe3017b9469775d88f83455c4e4230048d9907598ef3d3f9d56"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/UHTA7M5KJ65ZFP3ADOBHEQW4V5/bundle.json","state_url":"https://pith.science/pith/UHTA7M5KJ65ZFP3ADOBHEQW4V5/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/UHTA7M5KJ65ZFP3ADOBHEQW4V5/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-06-10T19:05:45Z","links":{"resolver":"https://pith.science/pith/UHTA7M5KJ65ZFP3ADOBHEQW4V5","bundle":"https://pith.science/pith/UHTA7M5KJ65ZFP3ADOBHEQW4V5/bundle.json","state":"https://pith.science/pith/UHTA7M5KJ65ZFP3ADOBHEQW4V5/state.json","well_known_bundle":"https://pith.science/.well-known/pith/UHTA7M5KJ65ZFP3ADOBHEQW4V5/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2019:UHTA7M5KJ65ZFP3ADOBHEQW4V5","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"a68430f993901bbcc9cb96b03682e5290cc434c8c793d367d1d522070a866504","cross_cats_sorted":["stat.ML"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2019-03-21T23:05:38Z","title_canon_sha256":"f981943727c6b5d5d66dd64bf9e5c4dc750ffd46d6257cfd3e7b6f6e9d57e892"},"schema_version":"1.0","source":{"id":"1903.09267","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1903.09267","created_at":"2026-05-17T23:50:40Z"},{"alias_kind":"arxiv_version","alias_value":"1903.09267v1","created_at":"2026-05-17T23:50:40Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1903.09267","created_at":"2026-05-17T23:50:40Z"},{"alias_kind":"pith_short_12","alias_value":"UHTA7M5KJ65Z","created_at":"2026-05-18T12:33:30Z"},{"alias_kind":"pith_short_16","alias_value":"UHTA7M5KJ65ZFP3A","created_at":"2026-05-18T12:33:30Z"},{"alias_kind":"pith_short_8","alias_value":"UHTA7M5K","created_at":"2026-05-18T12:33:30Z"}],"graph_snapshots":[{"event_id":"sha256:e516d53479e82fe3017b9469775d88f83455c4e4230048d9907598ef3d3f9d56","target":"graph","created_at":"2026-05-17T23:50:40Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Determining the optimal initial dose for warfarin is a critically important task. Several factors have an impact on the therapeutic dose for individual patients, such as patients' physical attributes (Age, Height, etc.), medication profile, co-morbidities, and metabolic genotypes (CYP2C9 and VKORC1). These wide range factors influencing therapeutic dose, create a complex environment for clinicians to determine the optimal initial dose. Using a sample of 4,237 patients, we have proposed a companion classification model to one of the most popular dosing algorithms (International Warfarin Pharmac","authors_text":"Adam Bress, Ashkan Sharabiani, Houshang Darabi, Rezvan Nazempour, William Galanter","cross_cats":["stat.ML"],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2019-03-21T23:05:38Z","title":"A Computer-Aided System for Determining the Application Range of a Warfarin Clinical Dosing Algorithm Using Support Vector Machines with a Polynomial Kernel Function"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1903.09267","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:a91de012c462196315c76dcf56c9580fbbd74795b3d0a93a749f46ab4d4301fc","target":"record","created_at":"2026-05-17T23:50:40Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"a68430f993901bbcc9cb96b03682e5290cc434c8c793d367d1d522070a866504","cross_cats_sorted":["stat.ML"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2019-03-21T23:05:38Z","title_canon_sha256":"f981943727c6b5d5d66dd64bf9e5c4dc750ffd46d6257cfd3e7b6f6e9d57e892"},"schema_version":"1.0","source":{"id":"1903.09267","kind":"arxiv","version":1}},"canonical_sha256":"a1e60fb3aa4fbb92bf601b827242dcaf51b34b307011cddb257f261b4349a7cd","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"a1e60fb3aa4fbb92bf601b827242dcaf51b34b307011cddb257f261b4349a7cd","first_computed_at":"2026-05-17T23:50:40.159451Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-17T23:50:40.159451Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"dArNISUvvCZrlF+3n14t+NPPOAdJnENhVbTV54bDrfqzsJ4PhJX1n2Exro1/3OYvui7+zvo2yaGfxd1c2rDcCA==","signature_status":"signed_v1","signed_at":"2026-05-17T23:50:40.160032Z","signed_message":"canonical_sha256_bytes"},"source_id":"1903.09267","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:a91de012c462196315c76dcf56c9580fbbd74795b3d0a93a749f46ab4d4301fc","sha256:e516d53479e82fe3017b9469775d88f83455c4e4230048d9907598ef3d3f9d56"],"state_sha256":"b12622fd13bf052937d6c305d8855cd0b8abefcf5729161f6d9c44cf43419520"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"/c4ltHIetHEEcAo9/0/VhI4IhIEBR9PYV7T8+lklPcb1efymqsDXJS8ox2mqRsf3tq/7HMjlJI/VPV4FPPulAA==","signed_message":"bundle_sha256_bytes","signed_at":"2026-06-10T19:05:45.912162Z","bundle_sha256":"f5bb192b821483d61caa12f497847149ba6cf11cc498e4117dad996469d0b906"}}